OnKure Therapeutics Inc. (OKUR) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    OnKure Therapeutics Inc.

    NASDAQ: OKUR · Real-Time Price · USD
    3.00
    0.29 (10.70%)
    At close: Oct 06, 2025, 10:11 AM

    OnKure Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -52.67M -35.31M -29.51M -39.77M
    Depreciation & Amortization
    		 662K 560K 387K 50K
    Stock-Based Compensation
    		 4.53M 199K 48K n/a
    Other Working Capital
    		 1.98M -1.71M 2.12M -2.8M
    Other Non-Cash Items
    		 316K n/a n/a 4.54M
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 -3.95M 6K 2.12M -2.8M
    Operating Cash Flow
    		 -51.12M -34.55M -26.95M -37.98M
    Capital Expenditures
    		 -52K -246K -1.13M -198K
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a -31.41M
    Sales Maturities Of Investments
    		 15.93M n/a 44.1M 8.23M
    Other Investing Acitivies
    		 n/a n/a -44.1M n/a
    Investing Cash Flow
    		 15.87M -246K -1.13M -23.38M
    Debt Repayment
    		 6M n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 51.22M -723K -1.38M n/a
    Financial Cash Flow
    		 116.13M 53.13M 26.46M 132.41M
    Net Cash Flow
    		 80.89M 18.33M -1.62M 71.05M
    Free Cash Flow
    		 -51.17M -34.79M -28.09M -38.18M

    Add to Watchlist